These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 7977509)
41. Ocular manifestation of hairy cell leukemia with dramatic response to 2-chloro-deoxy-adenosine. Robinson A; Eting E; Zeidman A; Djaldetti M; Mittelman M; Savir H Am J Ophthalmol; 1996 Jan; 121(1):97-9. PubMed ID: 8554090 [TBL] [Abstract][Full Text] [Related]
42. [Bone marrow fibrosis during therapy of hairy cell leukemia]. Dĕdic K; Zák P Cesk Patol; 2004 Jan; 40(1):22-4. PubMed ID: 15035057 [TBL] [Abstract][Full Text] [Related]
43. [Successful treatment with cladribine for hypoplastic hairy cell leukemia after long-term neutropenia]. Sakai R; Yamazaki E; Sakamoto H; Kanamori H; Ishigatsubo Y Rinsho Ketsueki; 2005 Nov; 46(11):1187-90. PubMed ID: 16440801 [TBL] [Abstract][Full Text] [Related]
44. Weekly intermittent 2-CdA is less toxic and equally efficacious when compared to continuous infusion in hairy cell leukaemia. Chacko J; Murphy C; Duggan C; O'Briain DS; Browne PV; McCann SR Br J Haematol; 1999 Jun; 105(4):1145-6. PubMed ID: 10554836 [No Abstract] [Full Text] [Related]
45. Acute myeloid leukemia following treatment with cladribine for hairy cell leukemia: a case report and review of the literature. Hassan R; Gupta M; Kern W; Ozer H Leuk Lymphoma; 2004 Oct; 45(10):2149-52. PubMed ID: 15370263 [TBL] [Abstract][Full Text] [Related]
46. Multicenter retrospective analysis regarding the clinical manifestations and treatment results in patients with hairy cell leukemia: twenty-four year Turkish experience in cladribine therapy. Hacioglu S; Bilen Y; Eser A; Sivgin S; Gurkan E; Yildirim R; Aydogdu I; Dogu MH; Yilmaz M; Kayikci O; Tombak A; Kuku I; Celebi H; Akay MO; Esen R; Korkmaz S; Keskin A Hematol Oncol; 2015 Dec; 33(4):192-8. PubMed ID: 25393847 [TBL] [Abstract][Full Text] [Related]
47. [Treatment of hairy cell leukemia with cladribine]. Aurer I; Mitrović Z; Kovacević-Metelko J; Radman I; Basić-Kinda S; Gjadrov-Kuvezdić K; Jakić-Razumović J; Dubravcić K; Ries S; Nola M; Zupancic-Salek S; Labar B Lijec Vjesn; 2007; 129(3-4):80-3. PubMed ID: 17557550 [TBL] [Abstract][Full Text] [Related]
49. Cladribine: from the bench to the bedside--focus on hairy cell leukemia. Greyz N; Saven A Expert Rev Anticancer Ther; 2004 Oct; 4(5):745-57. PubMed ID: 15485311 [TBL] [Abstract][Full Text] [Related]
50. Halogenoderma of the forearm caused by 2-chlorodeoxyadenosine treatment. Zevin S; Hershko C; Rosenmann E Am J Hematol; 1996 Nov; 53(3):209-10. PubMed ID: 8895703 [No Abstract] [Full Text] [Related]
51. Histological examination of the retinal ganglion layer in rabbits after experimental administration of the new immunosuppressive medicine--Cladribine. Kwietniewska M; Cybulska R; Kwietniewski P; Sekita-Krzak J; Czerny K Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):376-80. PubMed ID: 12898865 [TBL] [Abstract][Full Text] [Related]
52. Ultrastructural changes of retinal ganglion cells in rabbits of New Zealand breed after experimental administration of 2-CDA (Cladribine). Kwietniewska M; Cybulska R; Kwietniewski P; Sekita-Krzak J; Czerny K Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):381-6. PubMed ID: 12898866 [TBL] [Abstract][Full Text] [Related]